RhumbLine Advisers’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$106K Buy
7,853
+44
+0.6% +$654 ﹤0.01% 3507
2026
Q1
$120K Buy
7,809
+78
+1% +$1.3K ﹤0.01% 3329
2025
Q4
$139K Buy
7,731
+2,607
+51% +$44.9K ﹤0.01% 3335
2025
Q3
$82.5K Sell
5,124
-970
-16% -$14.2K ﹤0.01% 3566
2025
Q2
$66.4K Buy
6,094
+261
+4% +$2.92K ﹤0.01% 3624
2025
Q1
$72.8K Sell
5,833
-3,509
-38% -$57.8K ﹤0.01% 3483
2024
Q4
$185K Sell
9,342
-1,713
-15% -$19K ﹤0.01% 3237
2024
Q3
$90.3K Buy
11,055
+829
+8% +$5.63K ﹤0.01% 3526
2024
Q2
$69.6K Buy
10,226
+1,150
+13% +$7.86K ﹤0.01% 3609
2024
Q1
$45.5K Sell
9,076
-1
-0% -$2 ﹤0.01% 3645
2023
Q4
$20K Buy
9,077
+410
+5% +$978 ﹤0.01% 3769
2023
Q3
$21.3K Buy
8,667
+1,110
+15% +$5.31K ﹤0.01% 3773
2023
Q2
$59.1K Buy
+7,557
New +$54K ﹤0.01% 3644

Other funds holding MESO

RhumbLine Advisers's MESO Position: Q2 2026 in Review

RhumbLine Advisers increased its Mesoblast (MESO) stake by 0.56% in Q2 2026, buying an estimated $654 and bringing the position to 7,853 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #3507.

RhumbLine Advisers first reported a position in MESO in Q2 2023 and has held it in 13 quarters since. The position peaked at $185K in Q4 2024. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • RhumbLine Advisers held 7,853 shares of Mesoblast worth $106K as of Q2 2026.
  • RhumbLine Advisers bought 44 Mesoblast shares in Q2 2026, an estimated $654.
  • Mesoblast made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3507 holding.
  • RhumbLine Advisers first reported a position in Mesoblast in Q2 2023 and has held it in 13 quarters since.
  • RhumbLine Advisers's Mesoblast position peaked at $185K in Q4 2024.
  • 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.